Altered pre-lamin A processing is a common mechanism leading to lipodystrophy

Cristina Capanni, Elisabetta Mattioli, Marta Columbaro, Enrico Lucarelli, Veena K. Parnaik, Giuseppe Novelli, Manfred Wehnert, Vittoria Cenni, Nadir M. Maraldi, Stefano Squarzoni, Giovanna Lattanzi

Research output: Contribution to journalArticle

155 Citations (Scopus)

Abstract

Lipodystrophies are a heterogeneous group of human disorders characterized by the anomalous distribution of body fat associated with insulin resistance and altered lipid metabolism. The pathogenetic mechanism of inherited lipodystrophies is not yet clear; at the molecular level they have been linked to mutations of lamin A/C, peroxisome proliferator-activated receptor (PPARγ) and other seemingly unrelated proteins. In this study, we examined lamin A/C processing in three laminopathies characterized by lipodystrophic phenotypes: Dunnigan type familial partial lipodystrophy, mandibuloacral dysplasia and atypical Werner's syndrome. We found that the lamin A precursor was specifically accumulated in lipodystrophy cells. Pre-lamin A was located at the nuclear envelope and co-localized with the adipocyte transcription factor sterol regulatory element binding protein 1 (SREBP1). Using co-immunoprecipitation experiments, we obtained the first demonstration of an in vivo interaction between SREBP1 and pre-lamin A. Binding of SREBP1 to the lamin A precursor was detected in patient fibroblasts as well as in control fibroblasts forced to accumulate pre-lamin A by farnesylation inhibitors. In contrast, SREBP1 did not interact in vivo with mature lamin A or C in cultured fibroblasts. To gain insights into the effect of pre-lamin A accumulation in adipose tissue, we inhibited lamin A precursor processing in 3T3-L1 pre-adipocytes. Our results show that pre-lamin A sequesters SREBP1 at the nuclear rim, thus decreasing the pool of active SREBP1 that normally activates PPARγ and causing impairment of pre-adipocyte differentiation. This defect can be rescued by treatment with troglitazone, a known PPARγ ligand activating the adipogenic program.

Original languageEnglish
Pages (from-to)1489-1502
Number of pages14
JournalHuman Molecular Genetics
Volume14
Issue number11
DOIs
Publication statusPublished - Jun 1 2005

Fingerprint

Lamin Type A
Lipodystrophy
Sterol Regulatory Element Binding Protein 1
Peroxisome Proliferator-Activated Receptors
Adipocytes
Fibroblasts
troglitazone
Familial Partial Lipodystrophy
Werner Syndrome
Prenylation
Body Fat Distribution
Nuclear Envelope
Lipid Metabolism
Immunoprecipitation
Insulin Resistance
Adipose Tissue
Transcription Factors
Ligands
Phenotype
Mutation

ASJC Scopus subject areas

  • Genetics

Cite this

Altered pre-lamin A processing is a common mechanism leading to lipodystrophy. / Capanni, Cristina; Mattioli, Elisabetta; Columbaro, Marta; Lucarelli, Enrico; Parnaik, Veena K.; Novelli, Giuseppe; Wehnert, Manfred; Cenni, Vittoria; Maraldi, Nadir M.; Squarzoni, Stefano; Lattanzi, Giovanna.

In: Human Molecular Genetics, Vol. 14, No. 11, 01.06.2005, p. 1489-1502.

Research output: Contribution to journalArticle

Capanni, C, Mattioli, E, Columbaro, M, Lucarelli, E, Parnaik, VK, Novelli, G, Wehnert, M, Cenni, V, Maraldi, NM, Squarzoni, S & Lattanzi, G 2005, 'Altered pre-lamin A processing is a common mechanism leading to lipodystrophy', Human Molecular Genetics, vol. 14, no. 11, pp. 1489-1502. https://doi.org/10.1093/hmg/ddi158
Capanni, Cristina ; Mattioli, Elisabetta ; Columbaro, Marta ; Lucarelli, Enrico ; Parnaik, Veena K. ; Novelli, Giuseppe ; Wehnert, Manfred ; Cenni, Vittoria ; Maraldi, Nadir M. ; Squarzoni, Stefano ; Lattanzi, Giovanna. / Altered pre-lamin A processing is a common mechanism leading to lipodystrophy. In: Human Molecular Genetics. 2005 ; Vol. 14, No. 11. pp. 1489-1502.
@article{86ff29c083ce4063afd0924b67ddb659,
title = "Altered pre-lamin A processing is a common mechanism leading to lipodystrophy",
abstract = "Lipodystrophies are a heterogeneous group of human disorders characterized by the anomalous distribution of body fat associated with insulin resistance and altered lipid metabolism. The pathogenetic mechanism of inherited lipodystrophies is not yet clear; at the molecular level they have been linked to mutations of lamin A/C, peroxisome proliferator-activated receptor (PPARγ) and other seemingly unrelated proteins. In this study, we examined lamin A/C processing in three laminopathies characterized by lipodystrophic phenotypes: Dunnigan type familial partial lipodystrophy, mandibuloacral dysplasia and atypical Werner's syndrome. We found that the lamin A precursor was specifically accumulated in lipodystrophy cells. Pre-lamin A was located at the nuclear envelope and co-localized with the adipocyte transcription factor sterol regulatory element binding protein 1 (SREBP1). Using co-immunoprecipitation experiments, we obtained the first demonstration of an in vivo interaction between SREBP1 and pre-lamin A. Binding of SREBP1 to the lamin A precursor was detected in patient fibroblasts as well as in control fibroblasts forced to accumulate pre-lamin A by farnesylation inhibitors. In contrast, SREBP1 did not interact in vivo with mature lamin A or C in cultured fibroblasts. To gain insights into the effect of pre-lamin A accumulation in adipose tissue, we inhibited lamin A precursor processing in 3T3-L1 pre-adipocytes. Our results show that pre-lamin A sequesters SREBP1 at the nuclear rim, thus decreasing the pool of active SREBP1 that normally activates PPARγ and causing impairment of pre-adipocyte differentiation. This defect can be rescued by treatment with troglitazone, a known PPARγ ligand activating the adipogenic program.",
author = "Cristina Capanni and Elisabetta Mattioli and Marta Columbaro and Enrico Lucarelli and Parnaik, {Veena K.} and Giuseppe Novelli and Manfred Wehnert and Vittoria Cenni and Maraldi, {Nadir M.} and Stefano Squarzoni and Giovanna Lattanzi",
year = "2005",
month = "6",
day = "1",
doi = "10.1093/hmg/ddi158",
language = "English",
volume = "14",
pages = "1489--1502",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "11",

}

TY - JOUR

T1 - Altered pre-lamin A processing is a common mechanism leading to lipodystrophy

AU - Capanni, Cristina

AU - Mattioli, Elisabetta

AU - Columbaro, Marta

AU - Lucarelli, Enrico

AU - Parnaik, Veena K.

AU - Novelli, Giuseppe

AU - Wehnert, Manfred

AU - Cenni, Vittoria

AU - Maraldi, Nadir M.

AU - Squarzoni, Stefano

AU - Lattanzi, Giovanna

PY - 2005/6/1

Y1 - 2005/6/1

N2 - Lipodystrophies are a heterogeneous group of human disorders characterized by the anomalous distribution of body fat associated with insulin resistance and altered lipid metabolism. The pathogenetic mechanism of inherited lipodystrophies is not yet clear; at the molecular level they have been linked to mutations of lamin A/C, peroxisome proliferator-activated receptor (PPARγ) and other seemingly unrelated proteins. In this study, we examined lamin A/C processing in three laminopathies characterized by lipodystrophic phenotypes: Dunnigan type familial partial lipodystrophy, mandibuloacral dysplasia and atypical Werner's syndrome. We found that the lamin A precursor was specifically accumulated in lipodystrophy cells. Pre-lamin A was located at the nuclear envelope and co-localized with the adipocyte transcription factor sterol regulatory element binding protein 1 (SREBP1). Using co-immunoprecipitation experiments, we obtained the first demonstration of an in vivo interaction between SREBP1 and pre-lamin A. Binding of SREBP1 to the lamin A precursor was detected in patient fibroblasts as well as in control fibroblasts forced to accumulate pre-lamin A by farnesylation inhibitors. In contrast, SREBP1 did not interact in vivo with mature lamin A or C in cultured fibroblasts. To gain insights into the effect of pre-lamin A accumulation in adipose tissue, we inhibited lamin A precursor processing in 3T3-L1 pre-adipocytes. Our results show that pre-lamin A sequesters SREBP1 at the nuclear rim, thus decreasing the pool of active SREBP1 that normally activates PPARγ and causing impairment of pre-adipocyte differentiation. This defect can be rescued by treatment with troglitazone, a known PPARγ ligand activating the adipogenic program.

AB - Lipodystrophies are a heterogeneous group of human disorders characterized by the anomalous distribution of body fat associated with insulin resistance and altered lipid metabolism. The pathogenetic mechanism of inherited lipodystrophies is not yet clear; at the molecular level they have been linked to mutations of lamin A/C, peroxisome proliferator-activated receptor (PPARγ) and other seemingly unrelated proteins. In this study, we examined lamin A/C processing in three laminopathies characterized by lipodystrophic phenotypes: Dunnigan type familial partial lipodystrophy, mandibuloacral dysplasia and atypical Werner's syndrome. We found that the lamin A precursor was specifically accumulated in lipodystrophy cells. Pre-lamin A was located at the nuclear envelope and co-localized with the adipocyte transcription factor sterol regulatory element binding protein 1 (SREBP1). Using co-immunoprecipitation experiments, we obtained the first demonstration of an in vivo interaction between SREBP1 and pre-lamin A. Binding of SREBP1 to the lamin A precursor was detected in patient fibroblasts as well as in control fibroblasts forced to accumulate pre-lamin A by farnesylation inhibitors. In contrast, SREBP1 did not interact in vivo with mature lamin A or C in cultured fibroblasts. To gain insights into the effect of pre-lamin A accumulation in adipose tissue, we inhibited lamin A precursor processing in 3T3-L1 pre-adipocytes. Our results show that pre-lamin A sequesters SREBP1 at the nuclear rim, thus decreasing the pool of active SREBP1 that normally activates PPARγ and causing impairment of pre-adipocyte differentiation. This defect can be rescued by treatment with troglitazone, a known PPARγ ligand activating the adipogenic program.

UR - http://www.scopus.com/inward/record.url?scp=20444449733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20444449733&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddi158

DO - 10.1093/hmg/ddi158

M3 - Article

C2 - 15843404

AN - SCOPUS:20444449733

VL - 14

SP - 1489

EP - 1502

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 11

ER -